Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies994
Exvastat
Exvastat is a preclinical-stage pharmaceutical company that develops drugs to cure acute respiratory distress syndrome.
Sector
Subsector
Location
total rounds
total raised
Galleon Pharmaceuticals
Galleon Pharmaceuticals develops medicines for breathing-control conditions in the US.
Sector
Subsector
Keywords
Location
total rounds
total raised
Nexalin Technology
Nexalin Technology develops transcranial electrical stimulation equipment for the treatment of anxiety, insomnia, and depression.
Sector
Subsector
Keywords
Location
total rounds
total raised
SEEK Group
SEEK Group develops pharmaceutical drugs to improve human health by bringing safe, effective and low-cost treatments to patients.
Sector
Subsector
Location
Financials
Funding Rounds1
Number of Funding Rounds
Money Raised
Their latest funding was raised on 18.12.2019. Their latest investor Shmuel Cabilly. Their latest round Series C
Pontifax
Pontifax is a healthcare-dedicated venture capital firm that finances pharmaceutical and life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors6
Number of lead investors
Number of investors
Shmuel Cabilly
Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated from the Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.
current job
count Of Investments
count Of Exists
Pontifax
Pontifax is a healthcare-dedicated venture capital firm that finances pharmaceutical and life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Wille AG
Wille AG
Location
count Of Investments
count Of Exists
Acquisitions1
Ideal Life acquired by Raziel Health
acquirer
date
type
Ideal Life
Ideal Life is a leading technology company in the connected health industry.
Sector
Subsector
Keywords
Location
People
Founders1
Jeffery Gruen
Jeff Gruen is Huron’s Chief Clinical Innovation Officer and a member of the firm’s Healthcare leadership team. He has a distinguished career as an executive, entrepreneur and advisor working across industries with a focus on population health, ACO risk models and care management. Dr. Gruen has been a leader in four digital health/care delivery model innovation companies, including Revolution Health Group, where he served as President of the Care Division. He also has extensive experience in managing risk at the interface between payers and providers and served as a Chief Medical Officer at United Health Group.
current job
organization founded
Jeffery Gruen